Hantson P, Wallemacq P, Brau M, Vanbinst R, Haufroid V, Mahieu P
Department of Intensive Care, Cliniques Universitaires St-Luc, Brussels, Belgium.
Intensive Care Med. 1999 May;25(5):528-31. doi: 10.1007/s001340050893.
Since the use of 4-methylpyrazole (4-MP) in the treatment of humans with methanol poisoning is poorly documented, we report two cases of acute methanol intoxication partially treated by this potent alcohol dehydrogenase (ADH) inhibitor.
Intensive Care Unit in a university hospital.
A 56-year-old man and an 18-year-old woman were observed, respectively, 41 and 16 h after the voluntary ingestion of an unknown amount of methanol.
In both cases, ethanol was used as the first antidote. In the first patient, hemodialysis was also performed on admission because a high methanol level (0.72 g/l) and visual impairment were noted. In the second patient, ethanol therapy was withdrawn after 12 h when clinical and biological signs of acute pancreatitis became evident. Both patients received multiple oral doses of 4-MP. No recurrence of metabolic acidosis occurred and the 4-MP therapy was well tolerated.
While the use of 4-MP is better documented in cases of ethylene glycol poisoning, it could also become an accepted option for the management of methanol poisoning since 4-MP offers advantages over ethanol therapy.
由于4-甲基吡唑(4-MP)用于治疗甲醇中毒患者的相关记录较少,我们报告两例急性甲醇中毒病例,这两例患者接受了这种强效乙醇脱氢酶(ADH)抑制剂的部分治疗。
大学医院重症监护病房。
一名56岁男性和一名18岁女性,分别在自愿摄入未知量甲醇后41小时和16小时被观察。
两例患者均首先使用乙醇作为解毒剂。首例患者入院时因甲醇水平高(0.72 g/l)且有视力损害,还进行了血液透析。第二例患者在急性胰腺炎的临床和生物学体征明显后,12小时后停用乙醇治疗。两名患者均多次口服4-MP。未出现代谢性酸中毒复发,且4-MP治疗耐受性良好。
虽然4-MP在乙二醇中毒病例中的应用记录更完善,但由于4-MP比乙醇治疗具有优势,可以成为治疗甲醇中毒的一个可接受的选择。